Range
7.87 - 8.32
Vol / Avg.
16.2K/216.1K
Div / Yield
-
52 Wk
8 - 16.22
Mkt Cap
182.6M
Payout Ratio
-
Open
8.25
P/E
-
Shares
22.8M
Outstanding
22.8M
Total Float
19.6M
Benzinga - 4 days ago
Benzinga - Jul 20, 2021, 11:52AM
Benzinga - Jul 20, 2021, 8:56AM
Benzinga - Jul 20, 2021, 6:31AM
Benzinga - Jul 20, 2021, 6:19AM
Benzinga - Jun 25, 2021, 1:10PM
Benzinga - Jun 25, 2021, 11:22AM
Benzinga - Jun 25, 2021, 10:58AM
Benzinga - Jun 25, 2021, 9:12AM
Benzinga - Jun 7, 2021, 2:10PM
Sector: Health Care.Industry: Biotechnology
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ELEVElevation Oncology-4.76%182.6M

Elevation Oncology Frequently Asked Questions

Q

How do I buy Elevation Oncology (ELEV) stock?

A

You can purchase shares of Elevation Oncology (NASDAQ: ELEV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Elevation Oncology's (ELEV) competitors?

A

Other companies in Elevation Oncology’s space includes: AVEO Pharmaceuticals (NASDAQ:AVEO), Cabaletta Bio (NASDAQ:CABA), Larimar Therapeutics (NASDAQ:LRMR), Infinity Pharmaceuticals (NASDAQ:INFI) and Gemini Therapeutics (NASDAQ:GMTX).

Q

What is the target price for Elevation Oncology (ELEV) stock?

A

The latest price target for Elevation Oncology (NASDAQ: ELEV) was reported by Wedbush on July 20, 2021. The analyst firm set a price target for 27.00 expecting ELEV to rise to within 12 months (a possible 237.50% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Elevation Oncology (ELEV)?

A

The stock price for Elevation Oncology (NASDAQ: ELEV) is $8 last updated Today at 4:06:48 PM.

Q

Does Elevation Oncology (ELEV) pay a dividend?

A

There are no upcoming dividends for Elevation Oncology.

Q

When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?

A

Elevation Oncology does not have any upcoming earnings scheduled.

Q

Is Elevation Oncology (ELEV) going to split?

A

There is no upcoming split for Elevation Oncology.

Q

What sector and industry does Elevation Oncology (ELEV) operate in?

A

Elevation Oncology is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.